Securities code: 688488 securities abbreviation: Jiangsu Aidea Pharmaceutical Co.Ltd(688488) Announcement No.: 2022-018 Jiangsu Aidea Pharmaceutical Co.Ltd(688488)
Self inspection report on the trading of the company’s shares by insiders and incentive objects of the restricted stock incentive plan in 2022
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
Jiangsu Aidea Pharmaceutical Co.Ltd(688488) (hereinafter referred to as “the company”) held the 21st Meeting of the first board of directors and the 17th meeting of the first board of supervisors on January 19, 2022, deliberated and adopted the proposal on the company’s restricted stock incentive plan in 2022 (Draft) > and its summary and other relevant proposals, It was posted on the website of Shanghai Stock Exchange (www.sse. Com. CN.) on January 20, 2022 Relevant announcements were disclosed on the.
In accordance with the relevant provisions of the measures for the administration of equity incentive of listed companies (hereinafter referred to as the “administrative measures”), the Listing Rules of shares on the science and Innovation Board of Shanghai Stock Exchange, the self regulatory guide for listed companies on the science and Innovation Board No. 4 – disclosure of equity incentive information and other laws, regulations and normative documents, The company, through the Shanghai Branch of China Securities Depository and Clearing Corporation Limited, provides insider information and incentive objects of the 2022 restricted stock incentive plan (hereinafter referred to as the “incentive plan”) within 6 months before the public disclosure of the draft incentive plan (i.e. from July 19, 2021 to January 19, 2022, hereinafter referred to as the “self inspection period”) Self inspection was conducted on the trading of the company’s shares. The details are as follows:
1、 Scope and procedure of verification
1. The objects of this verification are insiders of the incentive plan and all incentive objects.
2. The insiders of the incentive plan filled in the registration form of insiders.
3. The company inquired and confirmed with the Shanghai Branch of China Securities Depository and Clearing Co., Ltd. about the purchase and sale of the company’s shares during the self inspection period, and the Shanghai Branch of China Securities Depository and Clearing Co., Ltd. issued the inquiry certificate.
2、 Description of the purchase and sale of the company’s shares by the verification object
According to the inquiry certificate on Shareholding and share change of information disclosure obligors and the detailed list of shareholder share change issued by China Securities Depository and Clearing Co., Ltd. Shanghai Branch, the verification objects’ purchase and sale of the company’s shares during the self inspection of the incentive plan are as follows:
No. name of shareholders total purchases (shares) total sales (shares) during the trading period
1 Hu Tianjin July 19, 2021 – January 12, 2022 7268 5268
2 Darong 1000 4000 from August 9, 2021 to January 13, 2022
3 Gong Cailei August 23, 2021 December 13, 2021 65873 65973
After verification, according to the written instructions and commitments issued by the above three incentive objects, their trading of the company’s shares is entirely based on their independent judgment of the trading situation in the secondary market, which has nothing to do with the inside information of the incentive plan. When they buy and sell the company’s shares, they do not know the relevant information of the incentive plan, The company did not get the information of this incentive plan through the insider, and there was no case of using the relevant insider information of this incentive plan for stock trading.
3、 Conclusion
In the process of planning the incentive plan, the company strictly follows the measures for the administration of information disclosure of listed companies and the internal confidentiality system of relevant companies, limits the scope of personnel involved in planning and discussion, timely registers the relevant personnel and intermediaries of the company who have access to insider information, and takes corresponding confidentiality measures. Before the company publicly disclosed the announcement related to the incentive plan for the first time, no information disclosure was found.
After verification, within 6 months before the disclosure of the relevant announcement of the incentive plan, no insider was found to use the relevant insider information of the incentive plan to buy and sell stocks or disclose the relevant insider information of the incentive plan. The behavior of all verification objects met the relevant provisions of the administrative measures and there was no insider trading.
It is hereby announced.
Jiangsu Aidea Pharmaceutical Co.Ltd(688488) board of directors February 17, 2022
